Prediction of morbidity and mortality from cardiac allograft vasculopathy.
For assessing clinical events associated with cardiac allograft vasculopathy, parameters relating to nonimmunological or immunological risk factors, epicardial coronary vessels, microvasculature, or left ventricular function may be utilized.
Deng
M C
MC
Cardiac Transplant Research, Heart Failure Center & Div. of Circ. Phys., Columbia University College of Physicians & Surgeons, New York, N.Y. 10032, USA.
Baba
H A
HA
Plenz
G
G
Erren
M
M
Wilhelm
M J
MJ
Moennig
G
G
Scheld
H H
HH
D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000209:etiology* / Q000401:mortality; D003326:Coronary Circulation; D003331:Coronary Vessels / Q000000981:diagnostic imaging; D004730:Endothelium, Vascular / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000175:diagnosis / Q000276:immunology; D016027:Heart Transplantation / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D017078:Laser-Doppler Flowmetry; D008297:Male; D008833:Microcirculation; D011379:Prognosis; D012307:Risk Factors; D013318:Stroke Volume; D013997:Time Factors; D014184:Transplantation, Homologous; D018084:Ultrasonography, Interventional; D016277:Ventricular Function, Left / Q000502:physiology